CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study

This project intends to construct a multicenter retrospective study, retrospectively collect clinical, imaging, pathological and prognostic data of patients, establish a complete data management system, establish a prediction model based on CT radiomics characteristics by combining radiomics, and verify the internal and external sequence of the model, which will improve the preoperative clinical diagnosis level of MIT family translocation kidney cancer, and then guide personalized and precise diagnosis and treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Cell Carcinoma (RCC) Adenocarcinoma Carcinoma Carcinoma, Renal Cell Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pathological diagnosis of RCC;
Have complete clinical, pathological and follow-up data;
Renal CT plain scan and enhanced images can be obtained from the image storage and transmission system (PACS)

Exclusion criteria

Patients who are not suitable for treatment: patients with severe comorbidities or unable to receive any form of treatment;
Combined with other malignant tumors: have been treated with other malignant tumors (or have other untreated active malignancies at the same time);
Patients with poor CT image quality/absence;
Patients with missing clinical/pathological/follow-up data

Treatment and study plan

Primary outcomes

Postoperative renal tumor pathological diagnosis type

Time frame: 1 week

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Fujian Medical University

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2023
Study completion: 2023
First posted: Sep 19, 2025
Registry last updated: Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed